If the goal is to get people off of this medication, how do we know that it really does? We will only learn with real world evidence. And so so far, we have titrated off of the population and 97% have maintained weight loss of greater than 10%. There is no evidence yet, suggesting that people can do that sustainably.
Molly rides solo today as she breaks down Amazon’s new telehealth business, Amazon Clinic. (1:40) Then, Calibrate CEO Isabelle Kenyon joins Molly for another edition of the Next Unicorns! (9:30)
(0:00) Molly tees up today's topics!
(1:40) Molly breaks down Amazon clinic
(8:15) OpenPhone - Get an extra 20% off any plan for your first 6 months at https://openphone.com/twist
(9:30) Calibrate CEO & Founder Isabelle Kenyon joins Molly for the Next Unicorns to chat about calibrate and GLP-1s
(20:52) LinkedIn Marketing - Get a $100 LinkedIn ad credit at LinkedIn.com/nextunicorn
(22:30) Understanding how inflammation causes many chronic diseases + obesity epidemic
(35:51) MicroAcquire - Sell your business with no fees at https://try.microacquire.com/twist
(37:19) Calibrate’s enterprise business + inequality in healthcare
Check out Calibrate: https://www.joincalibrate.com
FOLLOW Jason: https://linktr.ee/calacanis
FOLLOW Molly: https://twitter.com/mollywood
Subscribe to our YouTube to watch all full episodes:
https://www.youtube.com/channel/UCkkhmBWfS7pILYIk0izkc3A?sub_confirmation=1